Godeaux, O., Kovac, M., Shu, D., Grupping, K., Campora, L., Douha, M., . . . Lal, H. (2017). Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Hum Vaccin Immunother.

Godeaux, Olivier, Martina Kovac, Daniel Shu, Katrijn Grupping, Laura Campora, Martine Douha, Thomas C. Heineman, e Himal Lal. "Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in Adults ≥ 50 years of Age With a Prior History of Herpes Zoster: A Phase III, Non-randomized, Open-label Clinical Trial." Hum Vaccin Immunother 2017.

Godeaux, Olivier, et al. "Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in Adults ≥ 50 years of Age With a Prior History of Herpes Zoster: A Phase III, Non-randomized, Open-label Clinical Trial." Hum Vaccin Immunother 2017.